A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
Phase 3
18+
36 sites in CA, CO, FL +10
About this study
This Phase 3 study is focused on people with obesity. The primary outcome being measured is Percent Change from baseline in body weight.
Based on ClinicalTrials.gov records.
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Percent Change from baseline in body weight
Secondary: Change from Baseline in Control of Eating Questionnaire (CoEQ), Change from Baseline in Diastolic Blood Pressure (DBP), Change from Baseline in EuroQoL 5-Dimension 5-Level (EQ5D-5L), Change from Baseline in Fasting Glucose, Change from Baseline in Fasting insulin, Change from Baseline in Food Noise Questionnaire (FNQ), Change from baseline in Fasting triglycerides, Change from baseline in High-density lipoprotein cholesterol
Endocrinology